Candesartan cilexetil/pioglitazoneAlternative Names: TCV-116/Actos; TCV-116/pioglitozone
Latest Information Update: 09 Nov 2010
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Antihypertensives; Benzimidazoles; Tetrazoles; Thiazolidinediones
- Mechanism of Action Angiotensin type 1 receptor antagonists; Peroxisome proliferator-activated receptor gamma agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension in diabetes
Most Recent Events
- 12 May 2010 Discontinued - Phase-III for Hypertension in diabetes in Japan (PO)